# Pilot Study to Evaluate a Noninvasive Electrocardiographic Monitoring Strategy Associated With Early Discharge in Patients With Conduction Disorders Following TAVI Implantation (IMPROVE Study)

Study · id `cardio:ct-nct07456280` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07456280](<https://clinicaltrials.gov/study/NCT07456280>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07456280

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

## Technical summary

Registry record NCT07456280. Randomized; no masking; primary purpose other. Start 2026-07-20 (actual); primary completion 2028-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT07456280, source copy `cardio:ctgov-nct07456280-2026-07-22`, retrieved 2026-10-26)
- Started: 2026-07-20 (actual) (ClinicalTrials.gov record NCT07456280, source copy `cardio:ctgov-nct07456280-2026-07-22`, retrieved 2026-10-26)
- Primary completion: 2028-07-01 (anticipated) (ClinicalTrials.gov record NCT07456280, source copy `cardio:ctgov-nct07456280-2026-07-22`, retrieved 2026-10-26)
- Completion: 2028-08-01 (anticipated) (ClinicalTrials.gov record NCT07456280, source copy `cardio:ctgov-nct07456280-2026-07-22`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT07456280, source copy `cardio:ctgov-nct07456280-2026-07-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07456280-2026-07-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pilot Study to Evaluate a Noninvasive Electrocardiographic Monitoring Strategy Associated With Early Discharge in Patients With Conduction Disorders Following TAVI Implantation (IMPROVE Study)
- Acronym: IMPROVE
- Condition: Severe Aortic Valve Stenosis
- Condition: Cardiovascular Diseases
- Intervention (Behavioral): Standard care
- Intervention (Device): PhysioMem PM 100 4G ambulatory monitoring system
- Lead sponsor: Hospital Universitari Vall d'Hebron Research Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Hospital Universitari Vall d'Hebron Research Institute (`cardio:org-hospital-universitari-vall-d-hebron-research-institute`)

## Provenance

Content hash: 8c89c3d1450e7d200f53828536401e3a61fddf72db435ab67e927c9f3f1dbdfe
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
